Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Dolby (DLB)

Dolby Q4 revenue rose to $307 million; GAAP EPS fell to $0.51 from $0.61

Mixed Impact 3 of 5 earnings Written later

Dolby Laboratories reported fourth-quarter and fiscal 2025 results for the periods ended September 26, 2025. Revenue rose year over year, but GAAP net income and GAAP earnings per share declined, while non-GAAP earnings per share increased. The company also gave fiscal 2026 revenue and EPS ranges and declared a $0.36 per share cash dividend.

Key points

  • Q4 fiscal 2025 total revenue was $307 million, up from $305 million; GAAP diluted EPS was $0.51, down from $0.61, and non-GAAP diluted EPS was $0.99, up from $0.81.
  • Fiscal 2025 total revenue was $1.35 billion, up from $1.27 billion; GAAP net income was $255 million, or $2.62 per diluted share, down from $262 million, or $2.69.
  • Fiscal 2026 guidance: total revenue of $1.390 billion to $1.440 billion; GAAP diluted EPS of $2.61 to $2.76; non-GAAP diluted EPS of $4.19 to $4.34.
  • Cash dividend of $0.36 per share payable December 10, 2025, to holders of record on December 2, 2025.

The filing

CompanyDolby (DLB)
Form8-K, current report
Filed with the SECNov 18, 2025, 4:15 PM ET
Accession number0001193125-25-286178

Items reported: 2.02 Results of Operations8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 18, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.